Found: 44
Select item for more details and to access through your institution.
From a burn scar to malignancy! Marjolin's ulcer, a disease of wound neglect.
- Published in:
- Oxford Medical Case Reports, 2018, v. 2018, n. 8, p. N.PAG, doi. 10.1093/omcr/omy044
- By:
- Publication type:
- Article
Methicillin-resistant Staphylococcus aureus prostatic abscess after traumatic rectal injury.
- Published in:
- Oxford Medical Case Reports, 2018, v. 2018, n. 3, p. 108, doi. 10.1093/omcr/omx111
- By:
- Publication type:
- Article
Huge teratoma in a teenager.
- Published in:
- Oxford Medical Case Reports, 2017, v. 2017, n. 8, p. 140, doi. 10.1093/omcr/omx040
- By:
- Publication type:
- Article
Topical 5-Fluorouracil associated skin reaction.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Air in the portal vein: where computed tomography saved a patient's life.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Impact of age on treatment utilization for newly diagnosed multiple myeloma: a nationwide retrospective cohort study.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01164-x
- By:
- Publication type:
- Article
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01003-z
- By:
- Publication type:
- Article
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00998-9
- By:
- Publication type:
- Article
Clinical and Molecular Characteristics Associated with Survival in Advanced Melanoma Treated with Checkpoint Inhibitors.
- Published in:
- Journal of Oncology, 2018, p. 1, doi. 10.1155/2018/6279871
- By:
- Publication type:
- Article
Time‐to‐event surrogate end‐points in multiple myeloma randomised trials from 2005 to 2019: A surrogacy analysis.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 5, p. 587, doi. 10.1111/bjh.18568
- By:
- Publication type:
- Article
Second primary malignancies after tandem autologous hematopoietic stem cell transplantation for multiple myeloma.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 11, p. 2222, doi. 10.1002/ajh.27452
- By:
- Publication type:
- Article
Corneal toxicity with belantamab mafodotin: Multi‐institutional real‐life experience.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. E451, doi. 10.1002/ajh.26728
- By:
- Publication type:
- Article
Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi‐institutional experience.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. E276, doi. 10.1002/ajh.26580
- By:
- Publication type:
- Article
First‐ versus second‐generation Bruton tyrosine kinase inhibitors in Waldenström's Macroglobulinemia: A systematic review and meta‐analysis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 942, doi. 10.1002/ajh.26552
- By:
- Publication type:
- Article
Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. E195, doi. 10.1002/ajh.26530
- By:
- Publication type:
- Article
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-44873-4
- By:
- Publication type:
- Article
Geographic and Racial Disparities in Access to Chimeric Antigen Receptor–T Cells and Bispecific Antibodies Trials for Multiple Myeloma.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 8, p. e2228877, doi. 10.1001/jamanetworkopen.2022.28877
- By:
- Publication type:
- Article
Enrollment of Black Participants in Pivotal Clinical Trials Supporting US Food and Drug Administration Approval of Chimeric Antigen Receptor–T Cell Therapy for Hematological Malignant Neoplasms.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 4, p. e228161, doi. 10.1001/jamanetworkopen.2022.8161
- By:
- Publication type:
- Article
Characteristics of post hoc subgroup analyses of oncology clinical trials: a systematic review.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 6, p. 1, doi. 10.1093/jncics/pkad100
- By:
- Publication type:
- Article
Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 6, p. 1640, doi. 10.3390/jcm11061640
- By:
- Publication type:
- Article
PARP (Poly(ADP-Ribose) Polymerase) Inhibitors in Platinum-Sensitive Recurrent Ovarian Cancer: A Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Oncology Research & Treatment, 2018, v. 41, n. 4, p. 226, doi. 10.1159/000486418
- By:
- Publication type:
- Article
A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation.
- Published in:
- Cancers, 2024, v. 16, n. 6, p. 1116, doi. 10.3390/cancers16061116
- By:
- Publication type:
- Article
Industry Payments to Physicians Endorsing Drugs and Devices on a Social Media Platform.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 24, p. 2131, doi. 10.1001/jama.2024.7832
- By:
- Publication type:
- Article
Participation of African American Persons in Clinical Trials Supporting U.S. Food and Drug Administration Approval of Cancer Drugs.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Adverse Event Reporting in Randomized Clinical Trials for Multiple Myeloma.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2342195, doi. 10.1001/jamanetworkopen.2023.42195
- By:
- Publication type:
- Article
Seizure Associated Takotsubo Syndrome: A Rare Combination.
- Published in:
- Case Reports in Cardiology, 2017, p. 1, doi. 10.1155/2017/8458054
- By:
- Publication type:
- Article
Autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia.
- Published in:
- Clinical Case Reports, 2020, v. 8, n. 6, p. 1112, doi. 10.1002/ccr3.2816
- By:
- Publication type:
- Article
Differential Diagnosis and Therapeutic Advances in Multiple Myeloma: A Review Article.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2023, v. 13, p. 33, doi. 10.2147/BLCTT.S272703
- By:
- Publication type:
- Article
Treatment Pattern, Healthcare Resource Utilization and Symptom Burden Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 6, p. e227, doi. 10.1016/j.clml.2024.02.006
- By:
- Publication type:
- Article
Bing-Neel Syndrome: Update on the Diagnosis and Treatment.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 3, p. e213, doi. 10.1016/j.clml.2021.09.014
- By:
- Publication type:
- Article
Programmed Cell Death-One Inhibition Therapy in Classical Hodgkin Lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Safety Analysis of Five Randomized Controlled Studies of Daratumumab in Patients With Multiple Myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Participation of African Americans in Clinical Trials Supporting FDA Approval of Hematological Malignancies Drugs.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S212, doi. 10.1016/j.clml.2019.07.079
- By:
- Publication type:
- Article
Pancreatic Adenocarcinoma Masquerading as Idiopathic Chronic Pancreatitis with Delayed Diagnosis.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Immunoglobulin D Multiple Myeloma Presenting as Spontaneous Fracture.
- Published in:
- Case Reports in Oncology, 2017, v. 10, n. 1, p. 272, doi. 10.1159/000466687
- By:
- Publication type:
- Article
A gene signature can predict risk of MGUS progressing to multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01472-y
- By:
- Publication type:
- Article
Perspectives on the Treatment of Multiple Myeloma.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. 200, doi. 10.1093/oncolo/oyad306
- By:
- Publication type:
- Article
Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 16, p. 2491, doi. 10.1002/cncr.34895
- By:
- Publication type:
- Article
Weight loss and dysgeusia in relapsed/refractory multiple myeloma patients treated with talquetamab.
- Published in:
- EJHaem, 2024, v. 5, n. 4, p. 789, doi. 10.1002/jha2.971
- By:
- Publication type:
- Article
B‐cell maturation antigen‐based therapies post‐talquetamab in relapsed or refractory multiple myeloma.
- Published in:
- EJHaem, 2024, v. 5, n. 3, p. 554, doi. 10.1002/jha2.896
- By:
- Publication type:
- Article
Follow up duration of phase III Multiple Myeloma Clinical Trials: A systematic review.
- Published in:
- EJHaem, 2023, v. 4, n. 3, p. 719, doi. 10.1002/jha2.680
- By:
- Publication type:
- Article
Variability of definition of high‐risk multiple myeloma across phase III clinical trials.
- Published in:
- EJHaem, 2023, v. 4, n. 2, p. 454, doi. 10.1002/jha2.675
- By:
- Publication type:
- Article
Gender disparities in multiple myeloma publications.
- Published in:
- EJHaem, 2022, v. 3, n. 3, p. 966, doi. 10.1002/jha2.470
- By:
- Publication type:
- Article
Targeting B Cell Maturation Antigen in Patients with Multiple Myeloma: Current Perspectives.
- Published in:
- OncoTargets & Therapy, 2023, v. 16, p. 441, doi. 10.2147/OTT.S370880
- By:
- Publication type:
- Article